The main finding presented here is that PTU, besides its anti-thyroid and anti-atherosclerotic effects, also serves as a gamma-secretase inhibitor to impede Notch3 signaling and experimental PAH in rats. Here, NOTCH3 is linked to pulmonary arterial hypertension.